How much does Ozempic cost in 2026?

Ozempic costs $349 a month at most doses if you pay Novo Nordisk’s self-pay price, and $499 a month at the top 2 mg dose, as of October 27, 2026. New patients pay $199 for each of their first two fills if they fill by December 31, 2026. With commercial insurance that covers it, Novo’s savings offer can bring a fill to $25; Medicare Part D plans set their own copays, and the list price is $1,027.51 per pen.

Everything below comes from Novo Nordisk’s NovoCare and Ozempic pages, its offer terms and its list-price page, read on October 27, 2026, plus CMS for Medicare. Novo can change or cancel its offers at any time.

Ozempic prices at a glance

Sources: Novo’s price guide, offer terms and list-price page.

Ozempic price by dose

Novo prices a month of the pen as one box of 1 pen. Each pen holds 4 weekly doses at 0.5 mg, 1 mg or 2 mg; the starter pen holds 4 doses of 0.25 mg and 2 of 0.5 mg, or 4 doses of 0.5 mg.

Scroll sideways to see the full table

A new patient, in Novo’s terms, is someone “new to the Ozempic Savings Offer who has not participated in any other prior Ozempic savings offers in the past 365 days.” The $199 price covers a maximum of two 28-day fills, the prescription must be filled by December 31, 2026, and the third fill moves to the standard price.

On the Ozempic label, you start at 0.25 mg a week for 4 weeks, then 0.5 mg. If blood sugar needs more control after at least 4 weeks, the dose can go to 1 mg, then 2 mg, the maximum. So most people pay $349 a month after the starter fills, and $499 only at 2 mg.

Ozempic also comes as a daily tablet for type 2 diabetes. Novo’s self-pay prices for a 30-tablet bottle are $149 at 1.5 mg, $199 at 4 mg and $299 at 9 mg, or $447, $597 and $897 for 3 bottles. Our Ozempic pill guide covers the tablets.

List price vs what you pay

Novo lists Ozempic at $1,027.51 per pen and per 30-tablet bottle, at every strength. Novo calls this the wholesale acquisition cost, “the price from a manufacturer to a wholesaler or a direct purchaser before any discounts or rebates are applied,” and adds that most people with health insurance don’t pay it. A cash buyer on the self-pay offer pays $349 or $499 instead. In February 2026, Novo announced it will cut the list price of the Ozempic 0.5 mg, 1 mg and 2 mg pens to $675 a month from January 1, 2027, and said self-pay prices won’t change.

Ozempic cost with insurance

With commercial insurance that covers Ozempic, Novo’s savings offer lets you “pay as little as $25, subject to a maximum savings of $100 per 1-month prescription, $200 per 2-month prescription, or $300 per 3-month prescription.” Novo says an activation is valid for up to 48 months. So:

• If your share for a month is $125 or less, you pay $25.
• If your share is $300 a month, the offer pays $100 and you pay $200.

Novo says coverage depends on your plan’s formulary, the FDA-approved use and any prior authorization or step therapy rules. Its terms also exclude plans with accumulator or maximizer programs, where manufacturer savings don’t count toward your deductible or set your share. People on federal employee, Affordable Care Act marketplace or state employee plans can use the offer; Novo doesn’t count those as government programs.

If your commercial plan doesn’t cover Ozempic, you can use the self-pay offer above instead, outside your insurance. Our Ozempic coupon guide quotes the offer terms in full, and our guide to whether insurance covers Ozempic covers plan rules.

Ozempic cost with Medicare

Novo says “most Medicare Part D plans cover Ozempic,” with costs that vary from plan to plan. Part D enrollees can’t use the $25 offer or get Ozempic through Novo’s Patient Assistance Program, according to Novo. They can use the self-pay offer, as long as they don’t bill Medicare or count the cost toward their out-of-pocket limit.

Prices under Medicare are set to fall. CMS negotiated a price of $274 for a 30-day supply of Ozempic, Rybelsus and Wegovy, effective January 1, 2027, against a 2024 list price of $959, a 71% discount (CMS). CMS gives the price for one 4 mg/3 mL Ozempic pen, the pen that holds four 1 mg doses, as $276.78. That is the price Part D plans and pharmacies work from, not your copay, which still depends on your plan.

The $50 Medicare GLP-1 Bridge doesn’t list Ozempic. Its form sends anyone with type 2 diabetes to their regular Part D plan.

Novo’s Patient Assistance Program provides free diabetes medicine to people who qualify. Medicaid members can’t use the $25 offer, and Novo says Medicaid likely has its own coverage for Ozempic.

Ozempic cost without insurance

Without coverage, you pay Novo’s self-pay price through NovoCare home delivery, which Novo says is free, or at a local pharmacy with the offer. A year takes about 13 pens.

Self-pay purchases don’t count toward a deductible or out-of-pocket limit. These are medication totals; an online program that prescribes Ozempic usually charges its own fee on top.

Ozempic for weight loss: the cheaper routes

Ozempic is approved to improve blood sugar in adults with type 2 diabetes and to lower heart and kidney risks in adults who have it. It has no weight-management approval, so prescribing it for weight loss alone is off-label, and Novo’s offer terms require a prescription for an FDA-approved use.

For weight loss, these cost the same or less:

• Wegovy pen: the semaglutide approved for weight loss. On NovoCare it is $199 for a new patient’s first two fills, then $349 a month from 0.25 mg to 2.4 mg and $399 for Wegovy HD 7.2 mg, so Wegovy’s top dose costs less than Ozempic’s. See our Wegovy cost guide.
• Wegovy pill: $149 a month at 1.5 mg, $199 at 4 mg and $299 at 9 mg and 25 mg on NovoCare.
• Compounded semaglutide: $65 to $299 a month at the programs we track, taking each program’s lowest ongoing price with medication and any required membership, as of October 2026. It is not Ozempic or Wegovy, and not a generic of either. A compounding pharmacy prepares it, it isn’t FDA-approved, and the FDA says compounded drugs “are not reviewed by the agency for safety, effectiveness or quality prior to marketing” (FDA).

Our Wegovy vs Ozempic guide compares the two labels and trials, and our Ozempic alternatives guide covers the rest of the field.

What online programs charge for Ozempic

Programs at $1,000 or more aren’t passing on Novo’s self-pay price. Ask which pharmacy fills the prescription and what you’ll pay at your dose. Our semaglutide provider rankings and brand-name GLP-1 rankings list the programs we track.

Before you start

Ozempic carries a boxed warning: in rodents, semaglutide caused thyroid C-cell tumors, and it is unknown whether Ozempic causes them, including medullary thyroid carcinoma (MTC), in people. It isn’t for anyone with a personal or family history of MTC or with MEN 2. Ask a licensed clinician whether it suits you.

The bottom line

As of October 27, 2026, Ozempic costs $349 a month self-pay at 0.25 mg to 1 mg and $499 at 2 mg, after two $199 starter fills for new patients, and $149 to $299 as a tablet. Commercial coverage with Novo’s offer can bring a fill to $25, while Medicare Part D sets its own copay and moves to a $274 negotiated price in 2027. For weight loss, Ozempic is off-label and Wegovy costs the same or less. Check your plan, then talk to a licensed clinician about which fits your diagnosis. More options on our weight-loss hub.